Humana Inc. (HUM)
NYSE: HUM · IEX Real-Time Price · USD
355.04
-1.16 (-0.33%)
May 20, 2024, 2:46 PM EDT - Market open
Humana Stock Forecast
Stock Price Forecast
The 18 analysts with 12-month price forecasts for Humana stock have an average target of 420, with a low estimate of 310 and a high estimate of 624. The average target predicts an increase of 18.30% from the current stock price of 355.04.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Humana stock from 20 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 4 | 4 | 3 | 4 | 4 |
| Buy | 9 | 8 | 8 | 7 | 7 | 6 |
| Hold | 3 | 6 | 6 | 9 | 10 | 10 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 18 | 18 | 18 | 19 | 21 | 20 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B of A Securities | B of A Securities | Hold Maintains $342 → $376 | Hold | Maintains | $342 → $376 | +5.90% | May 20, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $415 → $353 | Buy | Maintains | $415 → $353 | -0.57% | Apr 25, 2024 |
| UBS | UBS | Hold Maintains $334 → $326 | Hold | Maintains | $334 → $326 | -8.18% | Apr 25, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Maintains $391 → $360 | Hold | Maintains | $391 → $360 | +1.40% | Apr 25, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $415 → $370 | Buy | Maintains | $415 → $370 | +4.21% | Apr 25, 2024 |
Financial Forecast
Revenue This Year
113.00B
from 106.37B
Increased by 6.23%
Revenue Next Year
117.14B
from 113.00B
Increased by 3.67%
EPS This Year
16.52
from 20.00
Decreased by -17.38%
EPS Next Year
23.60
from 16.52
Increased by 42.82%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 119.4B | 130.1B | 141.6B | 143.3B | 154.8B |
| Avg | 113.0B | 117.1B | 122.9B | 136.6B | 148.9B |
| Low | 106.7B | 105.6B | 111.2B | 130.9B | 144.5B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 12.2% | 15.2% | 20.9% | 16.6% | 13.3% |
| Avg | 6.2% | 3.7% | 4.9% | 11.2% | 9.0% |
| Low | 0.3% | -6.5% | -5.0% | 6.6% | 5.8% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 19.78 | 27.55 | 39.56 | 39.90 | 42.21 |
| Avg | 16.52 | 23.60 | 30.02 | 35.36 | 40.60 |
| Low | 15.62 | 18.62 | 23.54 | 32.19 | 39.40 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.1% | 66.7% | 67.6% | 32.9% | 19.4% |
| Avg | -17.4% | 42.8% | 27.2% | 17.8% | 14.8% |
| Low | -21.9% | 12.7% | -0.3% | 7.3% | 11.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.